OncoMed and Celgene to jointly develop six cancer drugs

(Reuters) - OncoMed Pharmaceuticals Inc said Celgene Corp would develop and market six of its anti-cancer stem cell experimental drugs for an upfront payment of $155 million.

via Reuters: Health News Read More Here..